Blood thinners are a common treatment for patients suffering from conditions like deep vein thrombosis (DVT), atrial fibrillation (AFib), or for patients who are at an increased risk of...
With more than 9,000 Xarelto lawsuits currently pending in three different venues, the first MDL bellwether trials in Louisiana will be pivotal. After a heated debate, the first four...
Atrial fibrillation (AFib), or an irregular heartbeat, affects nearly 2.7 million Americans. The irregular heartbeat causes poor bloodflow, which increases a person’s risk of suffering a heart attack or...
As Janssen Pharmaceuticals and Bayer A.G. face more than 7,000 Xarelto lawsuits, a new study was published that will likely add to the company’s fears. A study published in...
With more than 7,000 lawsuits currently pending against Xarelto manufacturers, the litigation is reaching a fever pitch. Because of an increase in filings, plaintiffs were recently given an additional...
The controversy surrounding the anticoagulant Xarelto is reaching a fevered pitch, and the British Medical Journal (BMJ) just added more fuel to the fire. Johnson & Johnson (J&J) subsidiary...
As the Xarelto litigation moves closer to trial, some plaintiffs are looking to the Pradaxa settlement as an indication of how the litigation may be resolved. Both Xarelto and...
The INRatio device by Alere Inc. is at the heart of the litigation over the highly contested blood thinner, Xarelto. The device is now the subject of its own...
With the widespread popularity of the controversial anticoagulant Xarelto, it’s really no surprise the manufacturer, Janssen Pharmaceuticals, is facing more than 7,000 lawsuits over the drug’s risks. The Xarelto...
The controversy surrounding newer anticoagulants like Xarelto and Eliquis heated up recently after the FDA rejected an antidote manufactured by Portola Pharmaceuticals. On the heels of this significant drug...
